L
Lluís Puig
Researcher at Autonomous University of Barcelona
Publications - 510
Citations - 16811
Lluís Puig is an academic researcher from Autonomous University of Barcelona. The author has contributed to research in topics: Psoriasis & Medicine. The author has an hindex of 56, co-authored 427 publications receiving 13381 citations. Previous affiliations of Lluís Puig include Jikei University School of Medicine & Pompeu Fabra University.
Papers
More filters
Journal ArticleDOI
Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study.
Kristian Reich,Ina Zschocke,Hervé Bachelez,E.M.G.J. de Jong,Paolo Gisondi,Lluís Puig,Richard B. Warren,Ulrich Mrowietz +7 more
TL;DR: There is strong medical need for a topical medication, which is highly efficacious, easy‐to‐use and preferred by both physicians and patients.
Journal ArticleDOI
Biosimilars for Psoriasis: Clinical Studies to Determine Similarity.
Andrew Blauvelt,Lluís Puig,Sergio Chimenti,Ronald Vender,Murlidhar Rajagopalan,Ricardo Romiti,Lone Skov,Claus Zachariae,Helen S. Young,Errol P. Prens,A.D. Cohen,A.D. Cohen,J. M. Van der Walt,Jashin J. Wu +13 more
TL;DR: This review, written by members of the International Psoriasis Council, discusses how biosimilars are evaluated in a clinical setting, with emphasis on extrapolation of indication, interchangeability and optimal clinical trial design.
Journal ArticleDOI
Therapeutic targeting of the IL-13 pathway in skin inflammation
Carla Tubau,Lluís Puig +1 more
TL;DR: This narrative literature review is focused on the pivotal role of IL-13 in the immunopathogenesis of AD and other skin diseases and indicates the central role of Dupilumab has demonstrated in the pathogenesis ofAD, asthma, and other diseases in the atopic spectrum.
Journal ArticleDOI
The safety of brodalumab for the treatment of psoriasis
Helena Iznardo,Lluís Puig +1 more
TL;DR: Bdalumab is a highly efficacious and comparably safe therapeutic choice in patients with moderate to severe psoriasis, especially when rapid control of the disease is desired.
Journal ArticleDOI
Multiple fibrofolliculomas and trichodiscomas.
TL;DR: It is suggested that benign neoplasms derived from the mesodermal component of the pilar apparatus may present in various combinations and may also be associated with other hamartomatous skin proliferations.